China Resources Double-Crane Pharmaceutical Co.,Ltd.’s Net Profit Rose 4.8% in First Three Quarters of 2021
China Resources Double-Crane Pharmaceutical Co.,Ltd. (华润双鹤药业股份有限公司) (600062.SH) reported a net profit of 924.2 million yuan in the first three quarters of 2021, up 4.8% year-on-year.
Meanwhile, the company posted 6.9 billion yuan in revenue, up 7.9% year-on-year.
At the end of the reporting period, it had 13.4 billion yuan in total assets and 2.9 billion yuan in total liabilities, with a liability-to-asset ratio of 22%.
This article was automatically produced by Caixin Automation on Nov. 3, 2021.
Download our app to receive breaking news alerts and read the news on the go.
Follow the Chinese markets in real time with Caixin Global’s new stock database.
- MOST POPULAR